BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2900618)

  • 1. [Medullary cancer of the thyroid. Apropos of 20 years' experience in France].
    Calmettes C
    Ann Endocrinol (Paris); 1988; 49(1):10-6. PubMed ID: 2900618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for medullary cancer of the thyroid in France.
    Calmettes C
    Horm Metab Res Suppl; 1989; 21():1-2. PubMed ID: 2807149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
    Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
    Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type II: clinical, biological and epidemiological features. French Medullary Study Group.
    Calmettes C
    Horm Res; 1989; 32(1-3):41-6. PubMed ID: 2575578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for medullary thyroid cancer in France: a national effort. French Medullary Study Group (GETC).
    Calmettes C; Chaventre A; Feingold N; Franc B; Guliana JM
    Henry Ford Hosp Med J; 1989; 37(3-4):120-1. PubMed ID: 2576941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medullary cancer of the thyroid].
    Calmettes C
    Bull Cancer; 1990; 77(11):1063-72. PubMed ID: 2275984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
    Rochiccioli P; Tauber MT; Pienkowski C
    J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
    Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
    Rays; 2000; 25(2):257-66. PubMed ID: 11370543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2b with a good prognosis.
    Kullberg BJ; Nieuwenhuijzen Kruseman AC
    Arch Intern Med; 1987 Jun; 147(6):1125-7. PubMed ID: 2884942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
    Grauer A; Raue F; Gagel RF
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary cancer of the thyroid and multiple endocrine neoplastic syndromes].
    Delisle MJ
    Rev Prat; 1992 Apr; 42(7):845-50. PubMed ID: 1351314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
    degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
    Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family screening in medullary thyroid carcinoma presenting without a family history.
    Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
    Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and prognosis of medullary cancer of the thyroid gland. Influence of national multidisciplinary cooperation].
    Guliana JM; Modigliani E; Guillausseau PJ; Aubert P; Milhaud G; Moukhtar MS; Calmettes C
    Presse Med; 1989 Mar; 18(10):521-4. PubMed ID: 2523043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
    Meybier H; Schmidt-Gayk H; Buhr H; Raue F
    Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.